It’s going to take all of us working together, doing whatever it takes, to make ALS a livable disease and ultimately find a cure. It’s going to take researchers, clinicians, and scientists across the globe, urgently collaborating to reach our common goal – a world without ALS.
It’s going to take people living with ALS, their caregivers, family members and loved ones across the country impassioned to pursue public policies that help discover new treatments, empower people living with ALS to live life on their own terms and help reduce harms associated with the disease.
We are pleased to share our 2022 Mid-Year Report, detailing the work and achievements that have shaped the first half of this year, touching on all aspects of our mission: research, care services and advocacy.
- We’ve continued to expand our worldwide research portfolio, including the launch of a new Seed Grant Program to support exploratory research that has the potential for a significant impact on the fight against ALS.
- We’re growing our nationwide network of Certified Treatment Centers and ALS clinics to ensure access of critical care for ALL people living with ALS, regardless of where they live. Two new clinics have received the designation as ALS Association Certified Treatment Centers of Excellence since the beginning of the year, with more than 25 clinics in the process of working to achieve the same.
- In addition to helping lead the fight for increased federal funding for ALS research and continued expanded access to telehealth, we are empowering the ALS community to join us in pressing the FDA to approve AMX0035, a treatment shown to be safe and effective at extending life and slowing disease progression.
While these are just a few examples of some of the work being done, none of these accomplishments would be possible without you. We deeply appreciate the support, advocacy and collaboration of the ALS community and are grateful to all of you for joining us in doing whatever it takes to end ALS.